Covid vaccine makers gear up to launch new-generation jabs in India

India currently does not have any XBB 1.5 variant-based vaccines in the market

New-generation Covid vaccines may soon be available in India as many companies prepare to launch them amid a rise in new cases in some parts of the world, particularly Singapore.

Hyderabad-based Biological E has begun clinical trials of next-generation Covid vaccine to combat the XBB1.5 variant of the Sars-CoV-2 virus and expects preliminary results in June.
 

A Subject Expert Committee (SEC) last month recommended granting permission to the Pune-based Serum Institute of India (SII) for an Omicron XBB1.5 variant-based Covid-19 vaccine, with a local clinical trial waiver for emergency use.
 

Currently, India does not have any XBB 1.5 variant-based vaccines available.